Bank of New York Mellon »

Armata Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $193k 30k 6.48

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Armata Pharmaceuticals

Madison Asset Management
BlackRock
Vanguard Capital Management
Millennium Management
Geode Capital Management
Dauntless Investment Group
Northern Trust
Vanguard Portfolio Management
Edgewood Management
Vanguard Fiduciary Trust
State Street Corporation
GSB Wealth Management
Renaissance Technologies
Bridgeway Capital Management
SeaCrest Wealth Management

View all funds holding Armata Pharmaceuticals